Business Description
Brii Biosciences Ltd
ISIN : KYG1645A1094
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 843.04 | |||||
Equity-to-Asset | 0.98 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 4.81 | |||||
Beneish M-Score | 103.06 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 50.8 | |||||
3-Year EPS without NRI Growth Rate | 30.7 | |||||
3-Year FCF Growth Rate | -12.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.27 | |||||
9-Day RSI | 57.25 | |||||
14-Day RSI | 56.69 | |||||
6-1 Month Momentum % | -64.34 | |||||
12-1 Month Momentum % | -75.32 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 22.11 | |||||
Quick Ratio | 22.11 | |||||
Cash Ratio | 21.14 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.1 | |||||
Shareholder Yield % | 1.2 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -88269.19 | |||||
Net Margin % | -28329.63 | |||||
FCF Margin % | -96254.96 | |||||
ROE % | -5.51 | |||||
ROA % | -5.32 | |||||
ROIC % | -126.75 | |||||
ROC (Joel Greenblatt) % | -1256.01 | |||||
ROCE % | -5.88 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1270 | |||||
PB Ratio | 0.27 | |||||
Price-to-Tangible-Book | 0.3 | |||||
EV-to-EBIT | 9.75 | |||||
EV-to-EBITDA | 10.58 | |||||
EV-to-Revenue | -2906.24 | |||||
EV-to-FCF | 3.01 | |||||
Price-to-Net-Current-Asset-Value | 0.31 | |||||
Price-to-Net-Cash | 0.33 | |||||
Earnings Yield (Greenblatt) % | 10.26 | |||||
FCF Yield % | -70.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Brii Biosciences Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 0.675 | ||
EPS (TTM) (HK$) | -0.262 | ||
Beta | 0 | ||
Volatility % | 75.3 | ||
14-Day RSI | 56.69 | ||
14-Day ATR (HK$) | 0.095564 | ||
20-Day SMA (HK$) | 1.1555 | ||
12-1 Month Momentum % | -75.32 | ||
52-Week Range (HK$) | 0.85 - 4.24 | ||
Shares Outstanding (Mil) | 729.39 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Brii Biosciences Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Brii Biosciences Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Brii Biosciences Ltd Frequently Asked Questions
What is Brii Biosciences Ltd(HKSE:02137)'s stock price today?
When is next earnings date of Brii Biosciences Ltd(HKSE:02137)?
Does Brii Biosciences Ltd(HKSE:02137) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |